See the damaging effects of complement overactivation

Increased levels of complement activity have been found not just in the lesion itself, but in the area just outside of it: the pre-lesion.1

See the damaging effects of complement in action
View transcript

This is geographic atrophy, a world where damage to the retina is irreversibly etched into the landscape. In this advanced form of dry age-related macular degeneration, atrophic lesions form on the macula, causing loss of functional vision as they spread. To uncover what’s behind this destruction, our attention turns to the area outside the lesion, as we immerse ourselves in the little-known land of the pre-lesion where there’s still time to intervene. Below the surface, damage to the retina hasn’t yet started, but it's far from quiet. This swarming pack of proteins is called the complement system. Normally, they defend against pathogens and remove abnormal cells. Yet in geographic atrophy, or GA, too much complement activity can be insidious—in the lesion itself, but more surprisingly, in the pre-lesion where it hides unseen. This excessive complement activity depends on the leader of the pack: C3. Complement activation causes C3 to cleave, splitting it apart into the active fragments, C3a and C3b. Over by this photoreceptor, a flock of C3a’s have begun to swarm. Too much C3a can trigger chronic inflammation of the macula and cause some unwanted attention. Here, a pack of C3b’s are on the prowl, accumulating on cell surfaces, “tagging” them for phagocytosis by immune cells. What a display. But the hunt is far from over for C3b, who’s quite the busy bee—causing a subset of downstream components of the complement system to work together and form something new: the membrane attack complex, that latches onto and forms an opening in the cellular membranes of retinal pigment epithelial cells, or RPE, as well as photoreceptors. This is what can happen in the eye when the complement system becomes overactive. Seemingly healthy retinal cells die off, and the lesion continues its spread. So, our scientific exploration has shifted to the area called the pre-lesion. It’s where millions living with GA have the most to save.

C3 IS THE LINCHPIN OF COMPLEMENT OVERACTIVATION IN GA1-3
Classical
Lectin
Alternative
C3 is the linchpin of complement overactivation in GA
*C3b is involved in an amplification loop for complement activation1,4
All 3 complement pathways converge at C3, leading to cleavage of C3 into components C3a and C3b and downstream effects5
C3 is the linchpin of complement overactivation in GA
Inflammation

Activation and recruitment of inflammatory cells (by C3a and downstream protein C5a)6-8

Phagocytosis

Complement accumulation labeling cells for phagocytosis (by C3b)4,6,8

Cell membrane disruption

Cell membrane disruption from membrane attack complex formation (by downstream proteins C5b-9)2,3

C3 is the linchpin of complement overactivation in GA
All are thought to contribute to retinal cell death
Image does not reflect all proteins involved in the complement cascade.
Classical
Lectin
Alternative
C3 is the linchpin of complement overactivation in GA
*C3b is involved in an amplification loop for complement activation1,4
All 3 complement pathways converge at C3, leading to cleavage of C3 into components C3a and C3b and downstream effects5
C3 is the linchpin of complement overactivation in GA
Inflammation

Activation and recruitment of inflammatory cells (by C3a and downstream protein C5a)6-8

Phagocytosis

Complement accumulation labeling cells for phagocytosis (by C3b)4,6,8

Cell membrane disruption

Cell membrane disruption from membrane attack complex formation (by downstream proteins C5b-9)2,3

C3 is the linchpin of complement overactivation in GA
All are thought to contribute to retinal cell death
Image does not reflect all proteins involved in the complement cascade.
HEAR FROM YOUR PEERS

Experts share their insights and experiences managing GA patients.

Explore new territory in GA
Learn about the role of the complement system in GA secondary to AMD and receive updates from Apellis.

References: 1. Katschke KJ Jr, Xi H, Cox C, et al. Classical and alternative complement activation on photoreceptor outer segments drives monocyte-dependent retinal atrophy. Sci Rep. 2018;8(1):7348. doi:10.1038/s41598-018-25557-8. 2. Mastellos DC, Reis ES, Ricklin D, Smith RJ, Lambris JD. Complement C3-targeted therapy: replacing long-held assertions with evidence-based discovery. Trends Immunol. 2017;38(6):383-394. doi:10.1016/j.it.2017.03.003. 3. Ricklin D, Reis ES, Mastellos DC, Gros P, Lambris JD. Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense. Immunol Rev. 2016;274(1):33-58. doi:10.1111/imr.12500. 4. Seddon JM, Yu Y, Miller EC, et al. Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nat Genet. 2013;45(11):1366-1370. doi:10.1038/ng.2741. 5. Yates JRW, Sepp T, Matharu BK, et al; Genetic Factors in AMD Study Group. Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med. 2007;357(6):553-561. doi:10.1056/NEJMoa072618. 6. Smailhodzic D, Klaver CC, Klevering BJ, et al. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration. Ophthalmology. 2012;119(2):339-346. doi:10.1016/j.ophtha.2011.07.056. 7. Heesterbeek TJ, Lechanteur YTE, Lorés-Motta L, et al. Complement activation levels are related to disease stage in AMD. Invest Ophthalmol Vis Sci. 2020;61(3):18. doi:10.1167/iovs.61.3.18. 8. Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT. Complement system part I - Molecular mechanisms of activation and regulation. Front Immunol. 2015;6:262. doi:10.3389/fimmu.2015.00262.